Data |
Ora |
Fonte |
Titolo |
20/2/2025 | 23:23 | EDGAR2 | Form 4/A - Statement of changes in beneficial ownership of.. |
19/2/2025 | 01:03 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
11/2/2025 | 22:18 | EDGAR2 | Form 8-K - Current report |
11/2/2025 | 22:16 | EDGAR2 | Form 424B5 - Prospectus [Rule 424(b)(5)] |
11/2/2025 | 14:02 | BW | Hyperfine Announces $6.0 Million Registered Direct Offering |
11/2/2025 | 14:00 | EDGAR2 | Form 8-K - Current report |
06/2/2025 | 22:05 | BW | Hyperfine Reports on Growing Evidence for the Use of Swoop®.. |
29/1/2025 | 15:00 | EDGAR2 | Form 8-K - Current report |
17/12/2024 | 15:00 | BW | Hyperfine Expands Global Market Reach with New Distribution.. |
05/12/2024 | 15:00 | BW | Hyperfine Announces Extensive Clinical Study Coverage at.. |
03/12/2024 | 15:00 | BW | Hyperfine Announces Strategic Leadership Additions to Drive.. |
21/11/2024 | 15:00 | BW | Hyperfine Swoop® Portable MR Brain Imaging System Meets New.. |
19/11/2024 | 15:00 | BW | Hyperfine Announces Ten Abstracts at RSNA, Highlighting the.. |
18/11/2024 | 23:41 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
13/11/2024 | 22:05 | BW | Hyperfine, Inc. to Participate in Upcoming Investor.. |
12/11/2024 | 23:00 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
12/11/2024 | 22:15 | EDGAR2 | Form 8-K - Current report |
12/11/2024 | 22:05 | GLOBE | Hyperfine, Inc. Reports Third Quarter 2024 Financial Results |
07/11/2024 | 15:00 | BW | Hyperfine Announces European Launch with CE Approval |
31/10/2024 | 14:00 | BW | Hyperfine Announces Alzheimer’s Research with Promising.. |
24/10/2024 | 22:05 | BW | Hyperfine, Inc. to Announce Third Quarter 2024 Financial.. |
01/10/2024 | 15:00 | BW | Hyperfine Swoop® Portable MR Imaging® System Utilized in.. |
23/9/2024 | 15:44 | BW | Hyperfine Announces Promising Interim Findings on the Value.. |
11/9/2024 | 14:05 | BW | Researchers to Monitor Astronaut Brain Health Using Images.. |
28/8/2024 | 22:05 | BW | Hyperfine, Inc. to Participate in Upcoming Investor.. |
16/8/2024 | 23:04 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
09/8/2024 | 22:01 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
08/8/2024 | 22:11 | EDGAR2 | Form 8-K - Current report |
08/8/2024 | 22:05 | GLOBE | Hyperfine, Inc. Reports Record Quarterly Revenue and Raises.. |
30/7/2024 | 15:00 | BW | Hyperfine Announces Presentation of Initial Data from.. |
24/7/2024 | 22:15 | EDGAR2 | Form 8-K - Current report |
17/7/2024 | 15:00 | BW | Hyperfine Announces FDA Clearance of Software Update That.. |
15/7/2024 | 15:00 | BW | Portable MRI as a Tissue Clock for Acute Ischemic Stroke:.. |
11/7/2024 | 22:05 | BW | Hyperfine, Inc. to Announce Second Quarter 2024 Financial.. |
10/7/2024 | 15:00 | BW | Hyperfine Expands European Market Reach with Additional.. |
25/6/2024 | 15:00 | BW | Clinical Research Using Swoop® System for Alzheimer's.. |
12/6/2024 | 22:04 | EDGAR2 | Form 8-K - Current report |
03/6/2024 | 22:05 | BW | Hyperfine, Inc. to Host Analyst and Investor Education.. |
31/5/2024 | 22:06 | EDGAR2 | Form 8-K - Current report |
28/5/2024 | 15:00 | BW | Hyperfine, Inc. Continues Global Market Expansion by.. |
22/5/2024 | 22:05 | BW | Hyperfine, Inc. to Present at the Jefferies Global.. |
22/5/2024 | 15:00 | BW | Hyperfine, Inc. Celebrates ASNR 2024 |
16/5/2024 | 23:33 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
14/5/2024 | 22:01 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
13/5/2024 | 22:13 | EDGAR2 | Form 8-K - Current report |
13/5/2024 | 22:05 | GLOBE | Hyperfine, Inc. Reports First Quarter 2024 Financial Results |
10/5/2024 | 15:00 | BW | Hyperfine, Inc. to Expand Global Market Reach with.. |
29/4/2024 | 22:05 | BW | Hyperfine, Inc. to Announce First Quarter 2024 Financial.. |
23/4/2024 | 15:00 | BW | Hyperfine, Inc. Takes the Stage at ISMRM with Seventeen.. |
17/4/2024 | 15:00 | BW | Leading Institutions Enroll First Alzheimer’s Patients.. |